Læknablaðið - 15.02.1996, Qupperneq 11

LÆKNABLAÐIÐ 1996; 82
121
HEIMILDIR
1. Gíslason Þ, Gíslason D, Blöndal Þ, Helgason H, Rafns-
son V. Öndunarfæraeinkenni fslendinga á aldrinum 20-
44 ára. Læknablaðið 1993; 79: 343-7.
2. Gíslason Þ, Tómasson K. Dánartíðni vegna astma, lang-
vinnrar berkjubólgu og lungnaþembu. Læknablaðið 1994;
80: 239-43.
3. Siafakas NM, Vermeire P, Pride NB, Paoletti P et al.
Optimal assessment and management of chronic obstruc-
tive pulmonary disease (COPD). ERS Consensus State-
ment. Eur Respir J 1995; 8: 1398-1420.
4. Vermeire P. Growing consensus in COPD? (Editorial.)
Eur Respir J 1995; 8: 1250-1.
5. Gerdtham UG, Hertzman P, Boman G, Jönsson J. Im-
pact of inhaled corticosteroids on asthma hospitalization
in Sweden: a pooled regression analysis. Research Report
of the Ekonomiska Forskningsinstitutet, Center for
Health Economics. Stockholm: School of Economics,
1993.
6. Rutten-van Molken MPMH, Van Doorslaer EKA, Jan-
sen MCC, Kerstjens HAM, Rutten FFH. Cost and effects
of inhaled corticosteroids and bronchodilators in asthma
and chronic obstructive pulmonary disease. Am J Crit
Care Med 1995; 151: 975-82.
7. Trautner C, Richter B, Berger M. Cost-effectiveness of a
structured treatment and teaching programme on asth-
ma. Eur Respir J 1993; 6: 1485-91.